ScandiDos AB (publ) (SDOS.ST) Stock Analysis & Winston Score

ScandiDos is a Swedish medical device company that makes quality control systems for radiation therapy — the type of treatment used to fight cancer. Its main product is the Delta4 platform, a device that hospitals and cancer clinics use to check that radiation beams are hitting tumors accurately before and during patient treatment. The company sells primarily to hospitals and radiotherapy centers around the world. ScandiDos earns money by selling its Delta4 hardware units and charging for software licenses, service contracts, and upgrades — a mix that helps create recurring revenue after the initial sale. The company operates globally, with customers across Europe, North America, and Asia, though it remains a small player with a market cap around $100 million. Its main competitive advantage is its established reputation in a specialized niche where accuracy is critical and switching costs are high. The key risk is that ScandiDos is currently unprofitable at the operating level, meaning it needs to grow sales volume significantly to cover its fixed costs and reach sustainable profitability.